Responsiveness and reliability were assessed by comparing WPS mean changes at Week 12 in American College of Rheumatology 20 % improvement criteria ( ACR20 ) or HAQ-DI Minimal Clinically Important Difference ( MCID ) 0.3 responders versus non-responders , as well as using standardized response means ( SRM ) .